XML 21 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
SALES      
Sales $ 337,814 $ 303,768 $ 381,765
COST OF SALES      
Total cost of sales 153,887 143,921 183,633
GROSS PROFIT 183,927 159,847 198,132
OPERATING EXPENSES      
Selling, general and administrative 136,234 131,827 177,378
Research and development 48,761 42,896 44,175
Restructuring costs 7,368 15,806 0
Impairment loss 0 0 35,213
Total operating expenses 192,363 190,529 256,766
LOSS FROM OPERATIONS (8,436) (30,682) (58,634)
OTHER EXPENSE (INCOME)      
Interest income 0 (340) (714)
Other expense, net 70 431 2,313
Interest expense 55 0 781
LOSS BEFORE INCOME TAX EXPENSE (BENEFIT) (8,561) (30,773) (61,014)
INCOME TAX EXPENSE (BENEFIT) 31,403 (31,402) 1,133
NET (LOSS) INCOME $ (39,964) $ 629 $ (62,147)
NET (LOSS) INCOME PER SHARE - BASIC (in dollars per share) $ (2.20) $ 0.04 $ (3.58)
NET (LOSS) INCOME PER SHARE - DILUTED (in dollars per share) $ (2.20) $ 0.04 $ (3.58)
Weighted average shares - Basic (in shares) 18,187,946 17,769,958 17,383,415
Weighted average shares - Diluted (in shares) 18,187,946 17,926,324 17,383,415
Product      
SALES      
Sales $ 251,103 $ 218,587 $ 289,679
COST OF SALES      
Total cost of sales 109,024 98,864 133,246
Service      
SALES      
Sales 86,711 85,181 92,086
COST OF SALES      
Total cost of sales $ 44,863 $ 45,057 $ 50,387